Study reveals novel strategy for in vivo blood stem cell gene therapy

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a unique window shortly after birth in which circulating blood stem cells can be effectively targeted with gene therapy directly in the body.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup